- Home
- BHAT vs ENSC Comparison
BHAT vs ENSC Comparison
Compare BHAT & ENSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHAT
- ENSC
- Stock Information
- Founded
- BHAT 2010
- ENSC 2003
- Country
- BHAT China
- ENSC United States
- Employees
- BHAT N/A
- ENSC N/A
- Industry
- BHAT Recreational Games/Products/Toys
- ENSC Biotechnology: Pharmaceutical Preparations
- Sector
- BHAT Consumer Discretionary
- ENSC Health Care
- Exchange
- BHAT Nasdaq
- ENSC Nasdaq
- Market Cap
- BHAT 12.3M
- ENSC 6.4M
- IPO Year
- BHAT 2019
- ENSC N/A
- Fundamental
- Price
- BHAT $1.66
- ENSC $2.10
- Analyst Decision
- BHAT
- ENSC
- Analyst Count
- BHAT 0
- ENSC 0
- Target Price
- BHAT N/A
- ENSC N/A
- AVG Volume (30 Days)
- BHAT 1.1M
- ENSC 54.6K
- Earning Date
- BHAT 04-30-2025
- ENSC 11-11-2025
- Dividend Yield
- BHAT N/A
- ENSC N/A
- EPS Growth
- BHAT N/A
- ENSC N/A
- EPS
- BHAT N/A
- ENSC N/A
- Revenue
- BHAT $18,724,190.00
- ENSC $7,413,722.00
- Revenue This Year
- BHAT N/A
- ENSC N/A
- Revenue Next Year
- BHAT N/A
- ENSC $1,354.55
- P/E Ratio
- BHAT N/A
- ENSC N/A
- Revenue Growth
- BHAT N/A
- ENSC 415.58
- 52 Week Low
- BHAT $1.51
- ENSC $1.62
- 52 Week High
- BHAT $45.00
- ENSC $14.67
- Technical
- Relative Strength Index (RSI)
- BHAT 46.47
- ENSC 48.61
- Support Level
- BHAT $1.62
- ENSC $2.02
- Resistance Level
- BHAT $1.83
- ENSC $2.19
- Average True Range (ATR)
- BHAT 0.18
- ENSC 0.10
- MACD
- BHAT 0.01
- ENSC 0.00
- Stochastic Oscillator
- BHAT 18.00
- ENSC 41.45
About BHAT Blue Hat Interactive Entertainment Technology
Blue Hat Interactive Entertainment Technology is focused on commodity trading, including chemicals, jewelry, and precious metals such as gold. It operates a gold and diamond trading and supply chain business. Its business model encompasses physical gold trading, diamond trading, gold derivatives trading, and the development of AI-enabled trading platforms. Its segments include Diamond trading, Commodity trading, Information service, Interactive toys - animation series, and Interactive toys - game series. It derives revenue from Diamond trading. The majority of its revenues are generated in PRC.
About ENSC Ensysce Biosciences Inc.
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, theTrypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform. The Company currently operates in one business segment, which is pharmaceuticals.